News
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Viz.ai for its Viz Subdural Plus module, designed for enhancing clinical decision-making. It is claimed to be the first ...
The US Food and Drug Administration (FDA) has granted 510 (k) clearance to Viz.ai for its Viz Subdural Plus module, designed for enhancing clinical decision-making. It is claimed to be the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback